rs371859345
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_002471.4(MYH6):c.1002T>A(p.Asp334Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,144 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002471.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH6 | NM_002471.4 | c.1002T>A | p.Asp334Glu | missense_variant, splice_region_variant | Exon 11 of 39 | ENST00000405093.9 | NP_002462.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH6 | ENST00000405093.9 | c.1002T>A | p.Asp334Glu | missense_variant, splice_region_variant | Exon 11 of 39 | 5 | NM_002471.4 | ENSP00000386041.3 | ||
MYH6 | ENST00000557461.2 | n.1069T>A | splice_region_variant, non_coding_transcript_exon_variant | Exon 11 of 14 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000727 AC: 11AN: 151276Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251258Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135820
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461752Hom.: 0 Cov.: 33 AF XY: 0.00000825 AC XY: 6AN XY: 727170
GnomAD4 genome AF: 0.0000727 AC: 11AN: 151392Hom.: 0 Cov.: 30 AF XY: 0.0000541 AC XY: 4AN XY: 73936
ClinVar
Submissions by phenotype
not specified Uncertain:2
The p.Asp334Glu variant in MYH6 has not been previously reported in individuals with cardiomyopathy, but has been identified in 2/10340 African chromosomes by t he Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs3 71859345). Computational prediction tools and conservation analysis do not provi de strong support for or against and impact to the protein. This variant is loca ted in the last three bases of the exon, which is part of the 5? splice region; however, computational tools do not suggest an impact to splicing. This informat ion is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Asp334Glu variant is uncertain. -
- -
Hypertrophic cardiomyopathy 14 Uncertain:1
This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 334 of the MYH6 protein (p.Asp334Glu). This variant is present in population databases (rs371859345, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with MYH6-related conditions. ClinVar contains an entry for this variant (Variation ID: 228883). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Reported in association with HCM in published literature (Ingles et al., 2019); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30681346) -
Cardiovascular phenotype Uncertain:1
The p.D334E variant (also known as c.1002T>A), located in coding exon 9 of the MYH6 gene, results from a T to A substitution at nucleotide position 1002. The aspartic acid at codon 334 is replaced by glutamic acid, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at